Risk factors for measles virus infection and susceptibility in persons aged 15 years and older in China: A multi-site case-control study, 2012-2013.
Adults
China
Measles elimination
Nosocomial transmission
Journal
Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899
Informations de publication
Date de publication:
03 04 2020
03 04 2020
Historique:
received:
10
09
2019
revised:
28
01
2020
accepted:
01
03
2020
pubmed:
17
3
2020
medline:
28
4
2021
entrez:
17
3
2020
Statut:
ppublish
Résumé
Endemic measles persists in China, despite >95% reported coverage of two measles-containing vaccine doses and nationwide campaign that vaccinated >100 million children in 2010. An increasing proportion of infections now occur among adults and there is concern that persistent susceptibility in adults is an obstacle to measles elimination in China. We performed a case-control study in six Chinese provinces between January 2012 to June 2013 to identify risk factors for measles virus infection and susceptibility among adults. Persons ≥15 years old with laboratory-confirmed measles were age and neighborhood matched with three controls. Controls had blood specimens collected to determine their measles IgG serostatus. We interviewed case-patients and controls about potential risk factors for measles virus infection and susceptibility. Unadjusted and adjusted matched odds ratios and 95% confidence intervals (CIs) were calculated via conditional logistic regression. We calculated attributable fractions for infection for risk factors that could be interpreted as causal. 899 cases and 2498 controls were enrolled. Among controls, 165 (6.6%) were seronegative for measles IgG indicating persistent susceptibility to infection. In multivariable analysis, hospital visit and travel outside the prefecture in the prior 1-3 weeks were significant risk factors for measles virus infection. Occupation and reluctance to accept measles vaccination were significant risk factors for measles susceptibility. The calculated attributable fraction of measles cases from hospital visitation was 28.6% (95% CI: 20.6-38.8%). Exposure to a healthcare facility was the largest risk factor for measles virus infection in adults in China. Improved adherence to hospital infection control practices could reduce risk of ongoing measles virus transmission and increase the likelihood of achieving and sustaining measles elimination in China. The use of control groups stratified by serological status identified distinct risk factors for measles virus infection and susceptibility among adults.
Identifiants
pubmed: 32173094
pii: S0264-410X(20)30339-X
doi: 10.1016/j.vaccine.2020.03.006
pmc: PMC10375840
mid: NIHMS1911635
pii:
doi:
Substances chimiques
Measles Vaccine
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
3210-3217Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Wkly Epidemiol Rec. 2013 Jun 7;88(23):233-40
pubmed: 23757799
Clin Infect Dis. 2015 Aug 15;61(4):615-8
pubmed: 25979309
Bull World Health Organ. 2014 May 1;92(5):340-7
pubmed: 24839323
Wkly Epidemiol Rec. 2014 Feb 7;89(6):45-52
pubmed: 24524163
Vaccine. 2016 Dec 12;34(51):6553-6560
pubmed: 27013438
Wkly Epidemiol Rec. 2010 Dec 3;85(49):490-4
pubmed: 21140596
Int J Epidemiol. 2019 Aug 1;48(4):1240-1251
pubmed: 30977801
Vaccine. 2016 Dec 12;34(51):6545-6552
pubmed: 26876440
Vaccine. 2014 Aug 27;32(38):4823-39
pubmed: 24280280
Vaccine. 2012 Jun 8;30(27):3996-4001
pubmed: 22521843
J Infect Dis. 2011 Jul;204 Suppl 1:S447-54
pubmed: 21666198
J Infect Dis. 2011 Jul;204 Suppl 1:S270-8
pubmed: 21666172
Open Forum Infect Dis. 2015 Feb 20;2(1):ofv006
pubmed: 26034757
PLoS One. 2012;7(4):e34401
pubmed: 22532829
Vaccine. 2015 Aug 7;33(33):4100-4
pubmed: 26117147
PLoS One. 2017 Sep 26;12(9):e0185465
pubmed: 28950011
Vaccine. 2016 Dec 12;34(51):6539-6544
pubmed: 27329182
BMC Infect Dis. 2018 Jan 12;18(1):36
pubmed: 29329528
Stat Med. 2000 Apr 30;19(8):1089-99
pubmed: 10790682
MMWR Morb Mortal Wkly Rep. 2018 May 04;67(17):491-495
pubmed: 29723171